Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 21 - 30 of 69 opportunities
This irrigating solution with superior chondro-protective properties reduces damage to cartilage cells (chondrocytes) during orthopaedic procedures. This helps preserve a healthy cartilage and lowers the risk of developing degenerative joint diseases, like osteoarthritis.
These thermo-responsive, xeno-free, polymer hydrogels for coating cell culture products and bioreactors allow mild, reagent-free cell passaging overcoming limitations in existing techniques for stem cell growth.
OSCAR™ is a gene amplification system with the potential to simplify the method of protein production in cultured mammalian cells.
A more efficient and lower cost method for synthesis of triphosphates using a polymer-supported reagent that eliminates many of the processing stages of other systems generating far greater yields and higher purity material.
Self-assembling polymers are being used to create nano particles highly loaded with active pharmaceutical ingredients. The approach can confer significant benefits including solubility enhancement, room temperture stability, peptidase protection and bioavalability enhancement. Patent protected polym...
Researchers at the University of Aberdeen have shown that the myeloid inhibitory C-type lectin like receptor has a previously unexpected role in rheumatoid arthritis. This provides a novel mechanism for therapeutic approaches and for diagnosis and prognosis of rheumatoid arthritis.
This compound screening technology works for, though not limited to, challenging screening targets. It can discriminate compounds that are cell permeable, show specific binding affinity to the target and forewarn of drug cytotoxicity in a single step.
New methods for cleaning surgical instruments that completely remove protein contamination, including prions – the infectious agents that cause Creutzfeldt-Jakob Disease (CJD) in humans.
Adherent glioma neural stem (GNS) cell lines that retain the characteristics of the original tumour-initiating cells, delivering a powerful model system for chemical and genetic screening.
Researchers at Aberdeen have developed a novel vaccination technology. Initially developed as a method of vaccinating fish without the need for injection, thus avoiding stress and infection risks. Testing to date has been carried out in fish, however the technology is believed to be potentially app...